BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 30325549)

  • 1. Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement.
    Radovic N; Ivanac G; Divjak E; Biondic I; Bulum A; Brkljacic B
    J Magn Reson Imaging; 2019 May; 49(5):1381-1390. PubMed ID: 30325549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of breast mass morphology with diffusion-weighted MRI: Beyond apparent diffusion coefficient.
    Kul S; Metin Y; Kul M; Metin N; Eyuboglu I; Ozdemir O
    J Magn Reson Imaging; 2018 Dec; 48(6):1668-1677. PubMed ID: 29734493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers.
    Kishimoto AO; Kataoka M; Iima M; Honda M; Miyake KK; Ohashi A; Ota R; Kataoka T; Sakurai T; Toi M; Togashi K
    Magn Reson Imaging; 2020 Sep; 71():161-169. PubMed ID: 32320723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution diffusion-weighted imaging compared with conventional diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging with regard to image quality and assessment of breast cancer morphology.
    Metin Y; Orhan Metin N; Kul S; Taşçı F; Özdemir O; Küpeli A
    Diagn Interv Radiol; 2023 Mar; 29(2):251-259. PubMed ID: 36987843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
    Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
    J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver agreement of PI-RADS v. 2 lexicon among radiologists with different levels of experience.
    Mussi TC; Yamauchi FI; Tridente CF; Tachibana A; Tonso VM; Recchimuzzi DZ; Leão LRS; Luz DC; Martins T; Baroni RH
    J Magn Reson Imaging; 2020 Feb; 51(2):593-602. PubMed ID: 31369194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
    Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
    Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
    Kul S; Metin Y; Bekircavusoglu S; Kul M
    Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.
    Ikeda DM; Hylton NM; Kinkel K; Hochman MG; Kuhl CK; Kaiser WA; Weinreb JC; Smazal SF; Degani H; Viehweg P; Barclay J; Schnall MD
    J Magn Reson Imaging; 2001 Jun; 13(6):889-95. PubMed ID: 11382949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response.
    Abdelrahman AS; Ekladious MEY; Badran EM; Madkour SS
    Diagn Interv Imaging; 2022 Nov; 103(11):524-534. PubMed ID: 35787988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast lesion morphology assessment with high and standard b values in diffusion-weighted imaging at 3 Tesla.
    Christner SA; Grunz JP; Schlaiß T; Curtaz C; Kunz AS; Huflage H; Patzer TS; Bley TA; Sauer ST
    Magn Reson Imaging; 2024 Apr; 107():100-110. PubMed ID: 38246517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.